The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Review: Diabetes, Obesity, and Cancer—Pathophysiology and Clinical Implications
Open accessAbstract
Obesity and diabetes have both been associated with an increased risk of cancer. In the face of increasing obesity and diabetes rates worldwide, this is a worrying trend for cancer rates. Factors such as hyperinsulinemia, chronic inflammation, antihyperglycemic medications, and shared risk factors have all been identified as potential mechanisms underlying the relationship. The most common obesity- and diabetes-related cancers are endometrial, colorectal, and postmenopausal breast cancers. In this review, we summarize the existing evidence that describes the complex relationship between obesity, diabetes, and cancer, focusing on epidemiological and pathophysiological evidence, and also reviewing the role of antihyperglycemic agents, novel research approaches such as Mendelian Randomization, and the methodological limitations of existing research. In addition, we also describe the bidirectional relationship between diabetes and cancer with a review of the evidence summarizing the risk of diabetes following cancer treatment. We conclude this review by providing clinical implications that are relevant for caring for patients with obesity, diabetes, and cancer and provide recommendations for improving both clinical care and research for patients with these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Pearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30150-5 · Cited by 307
RetractedPearson-Stuttard, J., Zhou, B., Kontis, V., Bentham, J., Gunter, M. J., & Ezzati, M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30366-2 · Cited by 265
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“Gestational diabetes mellitus (GDM) represents a unique prediabetes phase, as it is an early marker REVIEW of increased risk for subsequent diabetes and is often a hallmark of underlying insulin resistance (59).”
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Mechanisms, Pathophysiology, and Management of Obesity
Heymsfield, S. B., & Wadden, T. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1514009 · Cited by 1,867
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Booth, G., & Cheng, A. Y. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.010 · Cited by 1,220
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Bailey, C. E., Hu, C.-Y., You, Y. N., Bednarski, B. K., Rodriguez-Bigas, M. A., Skibber, J. M., Cantor, S. B., & Chang, G. J. (2015) · JAMA Surgery · doi:10.1001/jamasurg.2014.1756 · Cited by 1,077
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1500 · Cited by 1,048
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk
van den Brandt, P. A. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.6.514 · Cited by 1,023
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009 · cited 1×
“Cancers most commonly associated with diabetes are those of the pancreas, liver, endometrium, breast, colon, and bladder, while notably, prostate cancer has an inverse association with diabetes (2).”
Colorectal Cancer Incidence Patterns in the United States, 1974–2013
Siegel, R. L., Fedewa, S. A., Anderson, W. F., Miller, K. D., Ma, J., Rosenberg, P. S., & Jemal, A. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw322 · Cited by 1,002
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
Arnold, M., Pandeya, N., Byrnes, G., Renehan, A. G., Stevens, G. A., Ezzati, M., Ferlay, J., Miranda, J. J., Romieu, I., Dikshit, R., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71123-4 · Cited by 997
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Li, S., Shin, H. J., Ding, E. L., & van Dam, R. M. (2009) · JAMA · doi:10.1001/jama.2009.976 · Cited by 991 · cited 1×
“Increased adiposity also leads to reduced circulating adiponectin, an important adipokine that reduces levels of free fatty acids, improves lipid profiles, and decrease inflammatory cytokines (139).”
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 945
Bowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Overweight, obesity, and cancer risk
Bianchini, F., Kaaks, R., & Vainio, H. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00849-5 · Cited by 929
Molecular mechanisms of cancer development in obesity
Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3174 · Cited by 907
Tabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898
Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
Vuik, F. E., Nieuwenburg, S. A., Bardou, M., Lansdorp-Vogelaar, I., Dinis-Ribeiro, M., Bento, M. J., Zadnik, V., Pellisé, M., Esteban, L., Kaminski, M. F., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317592 · Cited by 886
Barone, B. B. (2008) · JAMA · doi:10.1001/jama.2008.824 · Cited by 881 · cited 1×
“Earlier meta-analyses documented higher mortality and poorer outcomes in persons with diabetes who develop any cancer (79), breast cancer (80), and colo-rectal cancer (81).”
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Tsilidis, K. K., Kasimis, J. C., Lopez, D. S., Ntzani, E. E., & Ioannidis, J. P. A. (2015) · BMJ · doi:10.1136/bmj.g7607 · Cited by 860
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
World Cancer Research Fund International
(2019) · The Grants Register 2019 · doi:10.1007/978-1-349-95810-8_1325 · Cited by 746
IARC Handbooks of Cancer Prevention: Breast cancer screening
Feig, S. A. (2003) · Cancer · doi:10.1002/cncr.11334 · Cited by 742
The IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Insulin Action · doi:10.1007/978-1-4615-5647-3_1 · Cited by 667
Causes of death among cancer patients
Zaorsky, N. G., Churilla, T. M., Egleston, B. L., Fisher, S. G., Ridge, J. A., Horwitz, E. M., & Meyer, J. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw604 · Cited by 657
(2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70095-4 · Cited by 652
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631 · cited 1×
“Explanations for the reverse association between diabetes and cancer include reduced circulating androgen levels (173) and PSA levels (174) among patients with diabetes.”
Neuhouser, M. L., Aragaki, A. K., Prentice, R. L., Manson, J. E., Chlebowski, R., Carty, C. L., Ochs-Balcom, H. M., Thomson, C. A., Caan, B. J., Tinker, L. F., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1546 · Cited by 630
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Vaughn, D. J., Nessel, L., Selby, J., & Strom, B. L. (2011) · Diabetes Care · doi:10.2337/dc10-1068 · Cited by 625
Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry
Sung, H., Siegel, R. L., Rosenberg, P. S., & Jemal, A. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30267-6 · Cited by 618
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Competing Risk of Death: An Important Consideration in Studies of Older Adults
Berry, S. D., Ngo, L., Samelson, E. J., & Kiel, D. P. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02767.x · Cited by 593
The IRS-signalling system: A network of docking proteins that mediate insulin action
White, M. F. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006806722619 · Cited by 534
Metformin and the Risk of Cancer
Suissa, S., & Azoulay, L. (2012) · Diabetes Care · doi:10.2337/dc12-0788 · Cited by 531
Pancreatic safety of incretin-based drugs–FDA and EMA assessment
Egan, A. G., Blind, E., Dunder, K., de Graeff, P. A., Hummer, B. T., Bourcier, T., & Rosebraugh, C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1314078 · Cited by 498
Le May, C., Chu, K., Hu, M., Ortega, C. S., Simpson, E. R., Korach, K. S., Tsai, M.-J., & Mauvais-Jarvis, F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602956103 · Cited by 498
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Aune, D., Greenwood, D. C., Chan, D. S. M., Vieira, R., Vieira, A. R., Navarro Rosenblatt, D. A., Cade, J. E., Burley, V. J., & Norat, T. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr398 · Cited by 488
Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis
Peairs, K. S., Barone, B. B., Snyder, C. F., Yeh, H.-C., Stein, K. B., Derr, R. L., Brancati, F. L., & Wolff, A. C. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3011 · Cited by 449
Lawlor, D. A., Smith, G. D., Bruckdorfer, K. R., Kundu, D., & Ebrahim, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16260-0 · Cited by 438
Obesity and Cancer Mechanisms: Cancer Metabolism
Hopkins, B. D., Goncalves, M. D., & Cantley, L. C. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.9712 · Cited by 414
Jonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
Steele, C. B., Thomas, C. C., Henley, S. J., Massetti, G. M., Galuska, D. A., Agurs-Collins, T., Puckett, M., & Richardson, L. C. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6639e1 · Cited by 408
Keum, N., Greenwood, D. C., Lee, D. H., Kim, R., Aune, D., Ju, W., Hu, F. B., & Giovannucci, E. L. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv088 · Cited by 395
SDRN Epidemiology Group, & Colhoun, H. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1453-1 · Cited by 393
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S.-B., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 384
The proliferating role of insulin and insulin-like growth factors in cancer
Gallagher, E. J., & LeRoith, D. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.06.007 · Cited by 380
Bariatric Surgery and the Risk of Cancer in a Large Multisite Cohort
Schauer, D. P., Feigelson, H. S., Koebnick, C., Caan, B., Weinmann, S., Leonard, A. C., Powers, J. D., Yenumula, P. R., & Arterburn, D. E. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002525 · Cited by 373
Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment
(2014) · New England Journal of Medicine · doi:10.1056/nejmx140026 · Cited by 372
Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women
The Premenopausal Breast Cancer Collaborative Group, Schoemaker, M. J., Nichols, H. B., Wright, L. B., Brook, M. N., Jones, M. E., O’Brien, K. M., Adami, H.-O., Baglietto, L., Bernstein, L., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1771 · Cited by 357
Meacham, L. R., Sklar, C. A., Li, S., Liu, Q., Gimpel, N., Yasui, Y., Whitton, J. A., Stovall, M., Robison, L. L., & Oeffinger, K. C. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.209 · Cited by 339
Elevated insulin receptor content in human breast cancer
Papa, V, Pezzino, V, Costantino, A., Belfiore, A., Giuffrida, D., Frittitta, L., Vannelli, G. B., Brand, R., Goldfine, I. D., & Vigneri, R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114868 · Cited by 338 · cited 1×
“Tumors of the breast, colon, lung, ovary, and thyroid express insulin receptors in high levels (155, 156), particularly the insulin receptor-A variant that is thought to mediate the direct effects of excess insulin on carcinogenesis (156).”
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Pisani, P. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450801954451 · Cited by 329
Harding, J. L., Shaw, J. E., Peeters, A., Cartensen, B., & Magliano, D. J. (2015) · Diabetes Care · doi:10.2337/dc14-1996 · Cited by 286
Novosyadlyy, R., Lann, D. E., Vijayakumar, A., Rowzee, A., Lazzarino, D. A., Fierz, Y., Carboni, J. M., Gottardis, M. M., Pennisi, P. A., Molinolo, A. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2141 · Cited by 282
Incident cancer burden attributable to excess body mass index in 30 European countries
Renehan, A. G., Soerjomataram, I., Tyson, M., Egger, M., Zwahlen, M., Coebergh, J. W., & Buchan, I. (2010) · International Journal of Cancer · doi:10.1002/ijc.24803 · Cited by 279
Diabetes and cancer: two diseases with obesity as a common risk factor
Garg, S. K., Maurer, H., Reed, K., & Selagamsetty, R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12124 · Cited by 275
The Natural Course of β-Cell Function in Nondiabetic and Diabetic Individuals
Festa, A., Williams, K., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1100 · Cited by 271
Guo, Y., Warren Andersen, S., Shu, X.-O., Michailidou, K., Bolla, M. K., Wang, Q., Garcia-Closas, M., Milne, R. L., Schmidt, M. K., Chang-Claude, J., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002105 · Cited by 268
Carreras-Torres, R., Johansson, M., Gaborieau, V., Haycock, P. C., Wade, K. H., Relton, C. L., Martin, R. M., Davey Smith, G., & Brennan, P. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx012 · Cited by 263
on behalf of the Diabetes and Cancer Research Consortium, Johnson, J. A., Carstensen, B., Witte, D., Bowker, S. L., Lipscombe, L., & Renehan, A. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2525-1 · Cited by 260
Self-citationAdenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study
Atkin, W., Wooldrage, K., Brenner, A., Martin, J., Shah, U., Perera, S., Lucas, F., Brown, J. P., Kralj-Hans, I., Greliak, P., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30187-0 · Cited by 249
Adolescence and breast carcinoma risk
Berkey, C. S., Frazier, A. L., Gardner, J. D., & Colditz, G. A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990601)85:11<2400::aid-cncr15>3.0.co;2-o · Cited by 248
Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer
Tamimi, R. M., Colditz, G. A., Hazra, A., Baer, H. J., Hankinson, S. E., Rosner, B., Marotti, J., Connolly, J. L., Schnitt, S. J., & Collins, L. C. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1702-0 · Cited by 238
The problem of “protopathic bias” in case-control studies
Horwitz, R. I., & Feinstein, A. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90363-0 · Cited by 235
Body Fatness at Young Ages and Risk of Breast Cancer Throughout Life
Baer, H. J., Tworoger, S. S., Hankinson, S. E., & Willett, W. C. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq045 · Cited by 233
de Vathaire, F., El-Fayech, C., Ben Ayed, F. F., Haddy, N., Guibout, C., Winter, D., Thomas-Teinturier, C., Veres, C., Jackson, A., Pacquement, H., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70323-6 · Cited by 226
Srokowski, T. P., Fang, S., Hortobagyi, G. N., & Giordano, S. H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5935 · Cited by 222
Leptin—Much More Than a Satiety Signal
Harris, R. B. S. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.45 · Cited by 222
Diabetes, Obesity, and Breast Cancer
Kang, C., LeRoith, D., & Gallagher, E. J. (2018) · Endocrinology · doi:10.1210/en.2018-00574 · Cited by 222
Sklar, C. A., Mertens, A. C., Walter, A., Mitchell, D., Nesbit, M. E., O'Leary, M., Hutchinson, R., Meadows, A. T., & Robison, L. L. (2000) · Medical and Pediatric Oncology · doi:10.1002/1096-911x(200008)35:2<91::aid-mpo1>3.0.co;2-g · Cited by 216
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Klil-Drori, A. J., Azoulay, L., & Pollak, M. N. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 210
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
Bansal, D., Bhansali, A., Kapil, G., Undela, K., & Tiwari, P. (2013) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.40 · Cited by 206
Tang, H., Dai, Q., Shi, W., Zhai, S., Song, Y., & Han, J. (2017) · Diabetologia · doi:10.1007/s00125-017-4370-8 · Cited by 206
Intentional weight loss and incidence of obesity-related cancers: the Iowa Women's Health Study
Parker, E. D., & Folsom, A. R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802437 · Cited by 203
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky, J., Wade, K. H., Richmond, R. C., Langdon, R. J., Bull, C. J., Tilling, K. M., Relton, C. L., Lewis, S. J., Davey Smith, G., & Martin, R. M. (2018) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-1177 · Cited by 194
Tsilidis, K. K., Capothanassi, D., Allen, N. E., Rizos, E. C., Lopez, D. S., van Veldhoven, K., Sacerdote, C., Ashby, D., Vineis, P., Tzoulaki, I., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0584 · Cited by 190
on behalf of the Diabetes and Cancer Research Consortium, Carstensen, B., Read, S. H., Friis, S., Sund, R., Keskimäki, I., Svensson, A.-M., Ljung, R., Wild, S. H., Kerssens, J. J., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3884-9 · Cited by 180
Goodwin, P. J., Stambolic, V., Lemieux, J., Chen, B. E., Parulekar, W. R., Gelmon, K. A., Hershman, D. L., Hobday, T. J., Ligibel, J. A., Mayer, I. A., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1224-1 · Cited by 177
Tallness and overweight during childhood have opposing effects on breast cancer risk
Hilakivi-Clarke, L., Forsén, T., Eriksson, J. G., Luoto, R., Tuomilehto, J., Osmond, C., & Barker, D. J. P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2109 · Cited by 170
Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature.
Liao, S., Li, J., Wei, W., Wang, L., Zhang, Y., Li, J., Wang, C., & Sun, S. (2011) · PubMed · Cited by 169
Johnson, J. A., Bowker, S. L., Richardson, K., & Marra, C. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2242-1 · Cited by 167
Cancer occurrence in Danish diabetic patients: duration and insulin effects
Carstensen, B., Witte, D. R., & Friis, S. (2012) · Diabetologia · doi:10.1007/s00125-011-2381-4 · Cited by 167
Clemens, E., van den Heuvel‐Eibrink, M. M., Mulder, R. L., Kremer, L. C. M., Hudson, M. M., Skinner, R., Constine, L. S., Bass, J. K., Kuehni, C. E., Langer, T., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30858-1 · Cited by 167
Gao, C., Patel, C. J., Michailidou, K., Peters, U., Gong, J., Schildkraut, J., Schumacher, F. R., Zheng, W., Boffetta, P., Stucker, I., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw129 · Cited by 163
Han, L., Ma, Q., Li, J., Liu, H., Li, W., Ma, G., Xu, Q., Zhou, S., & Wu, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027074 · Cited by 162
Incidence of Diabetes After Cancer Development: A Korean National Cohort Study
Hwangbo, Y., Kang, D., Kang, M., Kim, S., Lee, E. K., Kim, Y. A., Chang, Y. J., Choi, K. S., Jung, S.-Y., Woo, S. M., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1684 · Cited by 161
Increased Risk of Colorectal Cancer After Obesity Surgery
Derogar, M., Hull, M. A., Kant, P., Östlund, M. P., Lu, Y., & Lagergren, J. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e318288463a · Cited by 159
Masur, K., Vetter, C., Hinz, A., Tomas, N. M., Henrich, H., Niggemann, B., & Zänker, K. S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606050 · Cited by 156
Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015
Islami, F., Goding Sauer, A., Gapstur, S. M., & Jemal, A. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5639 · Cited by 153
Is obesity an inflammatory disease?
Ramos, E. J. B., Xu, Y., Romanova, I., Middleton, F. A., Chen, C., Quinn, R., Inui, A., Das, U. N., & Meguid, M. M. (2003) · Surgery · doi:10.1067/msy.2003.267 · Cited by 152
Fidler-Benaoudia, M. M., Reulen, R. C., Winter, D. L., Kelly, J. S., Jenkinson, H. C., Skinner, R., Frobisher, C., & Hawkins, M. M. (2016) · BMJ · doi:10.1136/bmj.i4351 · Cited by 152
Stein, K. B., Snyder, C. F., Barone, B. B., Yeh, H., Peairs, K. S., Derr, R. L., Wolff, A. C., & Brancati, F. L. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0944-8 · Cited by 149
Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis
Jing, W., Jin, G., Zhou, X., Zhou, Y., Zhang, Y., Shao, C., Liu, R., & Hu, X. (2011) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283481d89 · Cited by 146
Tsujimoto, T., Kajio, H., & Sugiyama, T. (2017) · International Journal of Cancer · doi:10.1002/ijc.30729 · Cited by 144
Young Adult Cancer: Influence of the Obesity Pandemic
Berger, N. A. (2018) · Obesity · doi:10.1002/oby.22137 · Cited by 141
IGF and Insulin Receptor Signaling in Breast Cancer
Belfiore, A., & Frasca, F. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9099-z · Cited by 136
GLP-1R Agonists Promote Normal and Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7
Koehler, J. A., Baggio, L. L., Yusta, B., Longuet, C., Rowland, K. J., Cao, X., Holland, D., Brubaker, P. L., & Drucker, D. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.005 · Cited by 133
Incidence of diabetes among postmenopausal breast cancer survivors
Lipscombe, L. L., Chan, W. W., Yun, L., Austin, P. C., Anderson, G. M., & Rochon, P. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2793-9 · Cited by 128
Self-citationWeight and weight changes in early adulthood and later breast cancer risk
ROSNER, B. A., Eliassen, A. H., Toriola, A. T., Chen, W. Y., Hankinson, S. E., Willett, W. C., Berkey, C. S., & Colditz, G. A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30627 · Cited by 124
Færch, K., Witte, D. R., Tabák, Á. G., Perreault, L., Herder, C., Brunner, E. J., Mika Kivimaki, B., & Vistisen, D. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70008-1 · Cited by 121
Intentional Weight Loss and Endometrial Cancer Risk
Luo, J., Chlebowski, R. T., HENDRYX, M. S., Rohan, T. E., Wactawski‐Wende, J., Thomson, C. A., Felix, A. S., Chen, C., Barrington, W. E., Coday, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.5822 · Cited by 121
Heuson, J.-C., Legros, N., & Heimann, R. (1972) · PubMed · Cited by 120
Shu, X., Wu, L., Khankari, N. K., Shu, X., Wang, T. J., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Milne, R. L., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy201 · Cited by 120
Association between markers of glucose metabolism and risk of colorectal cancer
Xu, J., Yao, Y., Wu, H., Duerksen-Hughes, P. J., Zhang, H., Li, P., Huang, J., Yang, J. J., Wu, Y., & Xia, D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011430 · Cited by 118
Circulating adipokines and risk of obesity related cancers: A systematic review and meta-analysis
Yoon, Y. S., Kwon, A.-R., Lee, Y. K., & Oh, S. W. (2019) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2019.03.006 · Cited by 116
Reduced Screening Mammography Among Women With Diabetes
Lipscombe, L. L., Hux, J. E., & Booth, G. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.18.2090 · Cited by 115
Self-citationBurden of cancer attributable to obesity, type 2 diabetes and associated risk factors
López-Suárez, A. (2018) · Metabolism · doi:10.1016/j.metabol.2018.10.013 · Cited by 115
The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study
Lega, I. C., Austin, P. C., Fischer, H. D., Fung, K., Krzyzanowska, M. K., Amir, E., & Lipscombe, L. L. (2018) · Diabetes Care · doi:10.2337/dc17-2012 · Cited by 113
Self-citationAssociation Between Metformin Therapy and Mortality After Breast Cancer
Lega, I. C., Austin, P. C., Gruneir, A., Goodwin, P. J., Rochon, P. A., & Lipscombe, L. L. (2013) · Diabetes Care · doi:10.2337/dc12-2535 · Cited by 112
Self-citationType 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies
Sona, M. F., Myung, S., Park, K., & Galsuren, J. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy047 · Cited by 112
Feigelson, H. S., Caan, B. J., Weinmann, S. A., Leonard, A. C., Powers, J. D., Yenumula, P. R., Arterburn, D. E., Koebnick, C., Altaye, M., & Schauer, D. P. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003331 · Cited by 110
Kowall, B., Stang, A., Rathmann, W., & Kostev, K. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3823 · Cited by 100
Addressing the Perfect Storm: Biomarkers in Obesity and Pathophysiology of Cardiometabolic Risk
Aleksandrova, K., Mozaffarian, D., & Pischon, T. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.275172 · Cited by 100
Johansson, M., Carreras‐Torres, R., Scélo, G., Purdue, M. P., Mariosa, D., Muller, D. C., Timpson, N. J., Haycock, P., Brown, K. M., Wang, Z., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002724 · Cited by 100
Risk of Diabetes Mellitus in Long-Term Survivors of Hodgkin Lymphoma
van Nimwegen, F. A., Schaapveld, M., Janus, C. P. M., Krol, A. D. G., Raemaekers, J. M. M., Kremer, L. C. M., Stovall, M., Aleman, B. M. P., & van Leeuwen, F. E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.4379 · Cited by 99
Marzioni, M., Alpini, G., Saccomanno, S., Candelaresi, C., Venter, J., Rychlicki, C., Fava, G., Francis, H., Trozzi, L., Glaser, S., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.007 · Cited by 96 · cited 1×
“Specifically, elevated levels of GLP-1 (both endogenous and exogenous) have been associated with decreased apoptosis and increased proliferation of cholangiocytes (117, 118).”
Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer
Mulligan, A. M., O’Malley, F. P., Ennis, M., Fantus, I. G., & Goodwin, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9471-x · Cited by 96
Association Between Weight Loss and the Risk of Cancer after Bariatric Surgery
Schauer, D. P., Feigelson, H. S., Koebnick, C., Caan, B. J., Weinmann, S. A., Leonard, A. C., Powers, J. D., Yenumula, P. R., & Arterburn, D. E. (2017) · Obesity · doi:10.1002/oby.22002 · Cited by 94
Setiawan, V. W., Stram, D. O., Porcel, J., Chari, S. T., Maskarinec, G., Le Marchand, L., Wilkens, L. R., Haiman, C. A., Pandol, S. J., & Monroe, K. R. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djy090 · Cited by 91
Crowe, F. L., Key, T. J., Allen, N. E., Appleby, P. N., Overvad, K., Grønbæk, H., Tjønneland, A. M., Halkjær, J., Dossus, L., Boeing, H., et al. (2010) · Annals of Human Biology · doi:10.3109/03014460.2010.507221 · Cited by 91
Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells
Lu, C., Chu, P., Hsia, S., Wu, C., Tung, Y., & Yen, G. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3844 · Cited by 90
The increasing burden of cancer attributable to high body mass index in Brazil
Rezende, L. F. M., Arnold, M., Rabacow, F. M., Levy, R. B., Claro, R. M., Giovannucci, E. L., & Eluf‐Neto, J. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.03.006 · Cited by 90
Plasma Leptin Levels and Risk of Breast Cancer in Premenopausal Women
Harris, H. R., Tworoger, S. S., Hankinson, S. E., ROSNER, B. A., & Michels, K. B. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0125 · Cited by 87
The association between diabetes and breast cancer stage at diagnosis: a population-based study
Lipscombe, L. L., Fischer, H. D., Austin, P. C., Fu, L., Jaakkimainen, R. L., Ginsburg, O., Rochon, P. A., Narod, S. A., & Paszat, L. F. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3323-5 · Cited by 87
Self-citationBordeleau, L. J., Yakubovich, N., Dagenais, G. R., Rosenstock, J., Probstfield, J. L., Yu, P. C., Rydén, L., Pīrāgs, V., Spinas, G. A., Birkeland, K. I., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1468 · Cited by 86
Holmqvist, A. S., Olsen, J. H., Andersen, K. K., Licht, S. D. F., Hjorth, L., Garwicz, S., Moëll, C., Anderson, H., Wesenberg, F., Tryggvadóttír, L., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.014 · Cited by 85
Wu, A. H., Kurian, A. W., Kwan, M. L., John, E. M., Lu, Y., Keegan, T. H. M., Gomez, S. L., Cheng, I. C., Shariff‐Marco, S., Caan, B. J., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1140 · Cited by 85
Aleksandrova, K., Nimptsch, K., & Pischon, T. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e596 · Cited by 84
Dalamaga, Μ. (2013) · World Journal of Experimental Medicine · doi:10.5493/wjem.v3.i3.34 · Cited by 82
Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study
Emaus, M. J., van Gils, C. H., Bakker, M. F., Bisschop, C. N. S., Monninkhof, E. M., Bueno-de-Mesquita, H. B., Travier, N., Berentzen, T. L., Overvad, K., Tjønneland, A. M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28926 · Cited by 82
Association between tamoxifen treatment and diabetes: A population‐based study
Lipscombe, L. L., Fischer, H. D., Yun, L., Gruneir, A., Austin, P. C., Paszat, L. F., Anderson, G., & Rochon, P. A. (2011) · Cancer · doi:10.1002/cncr.26559 · Cited by 81
Self-citationWu, J. W., Filion, K. B., Azoulay, L., Doll, M. K., & Suissa, S. (2016) · Diabetes Care · doi:10.2337/dc15-1816 · Cited by 80
Fuchs, O., Sheiner, E., Meirovitz, M., Davidson, E., Sergienko, R., & Kessous, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-016-4275-7 · Cited by 78
Dipeptidyl‐peptidase‐4 inhibitors and pancreatic cancer: a cohort study
Gokhale, M., Buse, J. B., Gray, C. L., Pate, V., Marquis, M. A., & Stürmer, T. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12379 · Cited by 75
Incidence of Diabetes in Colorectal Cancer Survivors
Singh, S., Earle, C. C., Bae, S. J., Fischer, H. D., Yun, L., Austin, P. C., Rochon, P. A., Anderson, G., & Lipscombe, L. L. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv402 · Cited by 74
Self-citationExendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis
Marzioni, M., Alpini, G., Saccomanno, S., Candelaresi, C., Venter, J., Rychlicki, C., Fava, G., Francis, H., Trozzi, L., & Benedetti, A. (2009) · Gut · doi:10.1136/gut.2008.150870 · Cited by 73
Lucenteforte, E., Bosetti, C., Talamini, R., Montella, M., Zucchetto, A., Pelucchi, C., Franceschi, S., Negri, E., Levi, F., & Vecchia, C. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603933 · Cited by 72
Overbeek, J. A., Bakker, M., van der Heijden, A. A. W. A., van Herk‐Sukel, M. P. P., Herings, R. M. C., & Nijpels, G. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3004 · Cited by 71 · cited 1×
“One recent meta-analysis did not find any association between DPP-4 inhibitors and any cancer type (115).”
Ma (2011) · Oncology Reports · doi:10.3892/or.2011.1150 · Cited by 71
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J., Montastruc, F., Platt, R. W., Bouganim, N., & Azoulay, L. (2018) · BMJ · doi:10.1136/bmj.k4880 · Cited by 71
Hsiao, F., Hsieh, P.-H., Huang, W.-F., Tsai, Y., & Gau, C. (2013) · Drug Safety · doi:10.1007/s40264-013-0080-4 · Cited by 69
Aravani, A., Downing, A., Thomas, J. D., Lagergren, J., Morris, E. J. A., & Hull, M. A. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.01.002 · Cited by 69
Berdan, C. A., Tangney, C., Scala, C., & Stolley, M. R. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0376-0 · Cited by 66
Serum Prostate-Specific Antigen Levels in Men With Type 2 Diabetes
Fukui, M., Tanaka, M., Kadono, M., Imai, S., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2008) · Diabetes Care · doi:10.2337/dc07-1962 · Cited by 66
Reilly, T. P., Graziano, M. J., Janovitz, E. B., Dorr, T. E., Fairchild, C. R., Lee, F. Y., Chen, J., Wong, T., Whaley, J. M., & Tirmenstein, M. A. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0053-3 · Cited by 63
Böehm, K., Sun, M., Larcher, A., Blanc-Lapierre, A., Schiffmann, J., Graefen, M., Sosa, J. F., Fred Saad, C., Parent, M., & Karakiewicz, P. I. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.07.006 · Cited by 63
Ptaszynska, A., Cohen, S. M., Messing, E. M., Reilly, T. P., JOHNSSON, E. K., & Johnsson, K. M. (2015) · Diabetes Therapy · doi:10.1007/s13300-015-0128-9 · Cited by 62
Pre-existing diabetes and breast cancer prognosis among elderly women
Luo, J., HENDRYX, M. S., Virnig, B. A., Wen, S., Chlebowski, R. T., Chen, C., Rohan, T. E., Tinker, L. F., Wactawski‐Wende, J., Lessin, L. S., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.249 · Cited by 60
Diabetes mellitus increases the risk of colorectal neoplasia: An updated meta-analysis
Luo, S., Li, J., Zhao, L., Yu, T., Zhong, W., Xia, Z., Shan, T., Ouyang, H., Yang, H., & Chen, Q. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.021 · Cited by 60
Prevalence and Trends of Receipt of Cancer Screenings Among US Women with Diagnosed Diabetes
Zhao, G., Ford, E. S., Ahluwalia, I. B., Li, C., & Mokdad, A. H. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0858-8 · Cited by 57
de Bruijn, K. M. J., Ruiter, R., de Keyser, C. E., Albert Hofman, D., Stricker, B. H. C., & van Eijck, C. H. J. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.019 · Cited by 56
Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study
Lavalette, C., Trétarre, B., Rébillard, X., Lamy, P., Cénée, S., & Menegaux, F. (2018) · Oncotarget · doi:10.18632/oncotarget.26128 · Cited by 56
Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin
Jonghe, S. D., Proctor, J., Vinken, P., Feyen, B., Wynant, I., Mariën, D., Geys, H., Mamidi, R. N. V. S., & Johnson, M. D. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.09.018 · Cited by 55
Jensen, M. V., Rugbjerg, K., Licht, S. D. F., Johansen, C., Schmiegelow, K., Andersen, K. K., & Winther, J. F. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0349 · Cited by 54
The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes
Lega, I. C., Shah, P. S., Margel, D., Beyene, J., Rochon, P. A., & Lipscombe, L. L. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0327 · Cited by 53
Self-citationInsulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro
Othman, E. M., Leyh, A., & Stopper, H. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.03.006 · Cited by 53
Drab, S. R. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666151223093841 · Cited by 53
Implementation Intentions and Colorectal Screening
Greiner, K. A., Daley, C. M., Epp, A., James, A. S., Yeh, H., Geana, M., Born, W. K., Engelman, K. K., Shellhorn, J., Hester, C. M., et al. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.08.005 · Cited by 51
Kowall, B., Rathmann, W., & Kostev, K. (2014) · Diabetes Care · doi:10.2337/dc14-0977 · Cited by 49
Hahn, T., Barth, S., Hofmann, W. E., Reich, O., Lang, I., & Desoyé, G. (1998) · International Journal of Cancer · Cited by 44
The temporal relationship between diabetes and cancer: A population‐based study
Lega, I. C., Wilton, A. S., Austin, P. C., Fischer, H. D., Johnson, J. A., & Lipscombe, L. L. (2016) · Cancer · doi:10.1002/cncr.30095 · Cited by 44
Self-citationOnitilo, A. A., Stankowski, R. V., Berg, R. L., Engel, J. M., Glurich, I., Williams, G. M., & Doi, S. A. R. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e32836162aa · Cited by 42
Gestational diabetes mellitus may be associated with increased risk of breast cancer
Park, Y., O’Brien, K. M., Zhao, S., Weinberg, C. R., Baird, D. D., & Sandler, D. P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.34 · Cited by 41
Diabetes Risk in Childhood Cancer Survivors: A Population-Based Study
Lega, I. C., Pole, J. D., Austin, P. C., Lau, C., Nathan, P. C., & Baxter, N. N. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.01.004 · Cited by 41
Self-citationTuccori, M., Wu, J. W., Yin, H., Majdan, A., & Azoulay, L. (2015) · Diabetes Care · doi:10.2337/dc15-1358 · Cited by 39
Long-acting insulin analogs and cancer
Sciacca, L., Vella, V., Frittitta, L., Tumminia, A., Manzella, L., Squatrito, S., Belfiore, A., & Vigneri, R. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.02.010 · Cited by 37
Mehtälä, J., Khanfir, H., Bennett, D., Ye, Y., Korhonen, P. A., & Hoti, F. J. (2018) · Diabetology International · doi:10.1007/s13340-018-0360-4 · Cited by 36
Wang, Y., Liu, X., Yan, P., Tang, J., Chen, T., Sun, Y., Zhou, W., Bi, Y., & Zhang, Z.-J. (2019) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000514 · Cited by 35
Chen, Y.-C., Ou, M.-C., Fang, C.-W., Lee, T., & Tzeng, S. (2019) · Cells · doi:10.3390/cells8040326 · Cited by 33
Sandholt, C. H., Allin, K. H., Toft, U., Borglykke, A., Ribel‐Madsen, R., Sparsø, T., Justesen, J. M., Harder, M. N., Jørgensen, T., Hansen, T. F., et al. (2013) · Obesity · doi:10.1002/oby.20540 · Cited by 31
Powe, C. E., Tobias, D. K., Michels, K. B., Chen, W. Y., Eliassen, A. H., Manson, J. E., ROSNER, B. A., Willett, W. C., Hu, F. B., Zhang, C., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0601 · Cited by 31
Short‐term risk of cancer among women with previous gestational diabetes: a population‐based study
Bejaimal, S. A. D., Wu, C. F., LOWE, J. M., Feig, D. S., Shah, B. R., & Lipscombe, L. L. (2015) · Diabetic Medicine · doi:10.1111/dme.12796 · Cited by 29
Self-citationAdult weight gain accelerates the onset of breast cancer
Azrad, M., Blair, C. K., Rock, C. L., Sedjo, R. L., Wolin, K. Y., & Demark‐Wahnefried, W. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05268-y · Cited by 29
Obesity and cancer—the evidence is fattening up
Kaaks, R., & Kuhn, T. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.168 · Cited by 28
Chuck, K. W., Hwang, M., Choi, K. S., Suh, M., Jun, J. K., & Park, B. (2017) · Epidemiology and Health · doi:10.4178/epih.e2017036 · Cited by 27
Cancer and Tuberculosis with Some Comments on Cancer and Other Diseases
Wilson, E. B., & Maher, H. C. (1932) · American Journal of Cancer · doi:10.1158/ajc.1932.227 · Cited by 25
Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature
Xie, C., Wang, W., Li, X., Shao, N., & Li, W. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1397117 · Cited by 24
Jayedi, A., Djafarian, K., Rezagholizadeh, F., Mirzababaei, A., Hajimohammadi, M., & Shab‐Bidar, S. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.09.004 · Cited by 21
Risk of diabetes after para-aortic radiation for testicular cancer
Groot, H. J., Gietema, J., Aleman, B., Incrocci, L., de Wit, R., Witjes, J., Groenewegen, G., de Brouwer, P., Meijer, O., Hulshof, M., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0248-x · Cited by 21
Drake, I., Gullberg, B., Sonestedt, E., Stocks, T., Bjartell, A., Wirfält, E., Wallström, P., & Orho-Melander, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.30824 · Cited by 20
Laspa, E., Christen, A., Efstathiadou, Z. A., Johnston, D. G., & Godsland, I. F. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02225.x · Cited by 20
Increased Risk of Colon Cancer in Men in the Pre-Diabetes Phase
Onitilo, A. A., Berg, R. L., Engel, J. M., Glurich, I., Stankowski, R. V., Williams, G. M., & Doi, S. A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070426 · Cited by 20
Cited by
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Obesity, Type 2 Diabetes, and Cancer Risk
Scully, T., Ettela, A., LeRoith, D., & Gallagher, E. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.615375 · Cited by 256
Sjöholm, K., Carlsson, L. M. S., Svensson, P.-A., Andersson-Assarsson, J. C., Kristensson, F., Jacobson, P., Peltonen, M., & Taube, M. (2022) · Diabetes Care · doi:10.2337/dc21-1335 · Cited by 84
GLP ‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials
Silverii, G. A., Marinelli, C., Bettarini, C., Del Vescovo, G. G., Monami, M., & Mannucci, E. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16489 · Cited by 67
Pharmacological Treatment of Obesity in Older Adults
Žižka, O., Haluzík, M., & Jude, E. B. (2024) · Drugs & Aging · doi:10.1007/s40266-024-01150-9 · Cited by 23
Metadata
- Authors
- Lega, I. C., & Lipscombe, L. L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2019-11-13
- Volume
- 41
- Issue
- 1
- Pages
- 33-52
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2983701642
- Cited by
- 364
- References
- 209
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.